| 2023-03-02 | The impact of coding germline variants on contralateral breast cancer risk and survival. | Morra, A; Mavaddat, N; Muranen, TA; Ahearn, TU; Allen, J; Andrulis, IL; Auvinen, P; Becher, H; Behrens, S; Blomqvist, C; Bojesen, SE; Bolla, MK; Brauch, H; Camp, NJ; Carvalho, S; Castelao, JE; Cessna, MH; Chang-Claude, J; Chenevix-Trench, G; NBCS Collaborators,; Czene, K; Decker, B; Dennis, J; Dörk, T; Dorling, L; Dunning, AM; Ekici, AB; Eriksson, M; Evans, DG; Fasching, PA; Figueroa, JD; Flyger, H; Gago-Dominguez, M; García-Closas, M; Geurts-Giele, WRR; Giles, GG; Guénel, P; Gündert, M; Hahnen, E; Hall, P; Hamann, U; Harrington, PA; He, W; Heikkilä, P; Hooning, MJ; Hoppe, R; Howell, A; Humphreys, K; kConFab Investigators,; Jakubowska, A; Jung, AY; Keeman, R; Kristensen, VN; Lubiński, J; Mannermaa, A; Manoochehri, M; Manoukian, S; Margolin, S; Mavroudis, D; Milne, RL; Mulligan, AM; Newman, WG; Park-Simon, T-W; Peterlongo, P; Pharoah, PDP; Rhenius, V; Saloustros, E; Sawyer, EJ; Schmutzler, RK; Shah, M; Spurdle, AB; Tomlinson, I; Truong, T; van Veen, EM; Vreeswijk, MPG; Wang, Q; Wendt, C; Yang, XR; Nevanlinna, H; Devilee, P; Easton, DF; Schmidt, MK |
